All In Biotech

Drug Trial Radar · NCT00000639

A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis

Last checked: Nov 20, 2026Latest source record: Nov 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

400

Actual

Start

Not stated

Primary completion

Not stated

Study completion Sep 1997

Sponsor

Sponsor type
NIH
Collaborators
Washington University School of Medicine
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the effectiveness and safety of amphotericin B plus flucytosine (5-fluorocytosine) compared to amphotericin B alone for a first episode of acute cryptococcal meningitis in AIDS patients, and to compare the effectiveness and safety of fluconazole versus itraconazole. At least 10 percent of patients with a low CD4 count and HIV infection will develop meningitis due to Cryptococcus neoformans. More effective treatments than the standard therapy need to be explored.

Conditions

  • Meningitis, Cryptococcal
  • HIV Infections

Interventions

  • ItraconazoleDrug

  • FlucytosineDrug

  • FluconazoleDrug

  • Amphotericin BDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

24 sites in 1 country. Site status is shown where the registry gives one.

  • USC CRS

    Los Angeles, California

  • Ucsf Aids Crs

    San Francisco, California

  • Univ. of Miami AIDS CRS

    Miami, Florida

  • Univ. of Hawaii at Manoa, Leahi Hosp.

    Honolulu, Hawaii

  • Northwestern University CRS

    Chicago, Illinois

  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic

    Indianapolis, Indiana

  • Methodist Hosp. of Indiana

    Indianapolis, Indiana

  • Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU

    New Orleans, Louisiana

  • Massachusetts General Hospital ACTG CRS

    Boston, Massachusetts

  • Bmc Actg Crs

    Boston, Massachusetts

  • Beth Israel Deaconess Med. Ctr., ACTG CRS

    Boston, Massachusetts

  • St. Louis ConnectCare, Infectious Diseases Clinic

    St Louis, Missouri

  • Washington U CRS

    St Louis, Missouri

  • SUNY - Buffalo, Erie County Medical Ctr.

    Buffalo, New York

  • Beth Israel Med. Ctr. (Mt. Sinai)

    New York, New York

  • Cornell University A2201

    New York, New York

  • Univ. of Rochester ACTG CRS

    Rochester, New York

  • Unc Aids Crs

    Chapel Hill, North Carolina

  • Carolinas HealthCare System, Carolinas Med. Ctr.

    Charlotte, North Carolina

  • Regional Center for Infectious Disease, Wendover Medical Center CRS

    Greensboro, North Carolina

  • Univ. of Cincinnati CRS

    Cincinnati, Ohio

  • The Ohio State Univ. AIDS CRS

    Columbus, Ohio

  • Hosp. of the Univ. of Pennsylvania CRS

    Philadelphia, Pennsylvania

  • Pitt CRS

    Pittsburgh, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.